Table 1.
Association between C-C motif chemokine ligand 5 (CCL5) and the clinicopathological factors in 111 breast carcinomas.
| Clinicopathological Factors | CCL5 Status | p-Value | |
|---|---|---|---|
| Negative (n = 72) | Positive (n = 39) | ||
| Age * | 56 (29–82) | 56 (27–87) | 0.40 |
| Menopause | |||
| Premenopausal | 29 | 12 | 0.32 |
| Postmenopausal | 43 | 27 | |
| Stage | |||
| I | 41 | 22 | 0.56 |
| II | 17 | 12 | |
| III | 14 | 5 | |
| Pathological T Factor | |||
| pT1 | 48 | 25 | 0.79 |
| pT2-4 | 24 | 14 | |
| Lymph Node Metastasis | |||
| Negative | 49 | 26 | 0.88 |
| Positive | 23 | 13 | |
| Histological Grade | |||
| 1 (well) | 32 | 11 | 0.0061 |
| 2 (intermediate) | 31 | 13 | |
| 3 (poor) | 9 | 15 | |
| ER | |||
| Negative | 8 | 13 | 0.0043 |
| Positive | 64 | 26 | |
| PR | |||
| Negative | 15 | 20 | 0.0010 |
| Positive | 57 | 19 | |
| HER2 | |||
| Negative | 63 | 33 | 0.67 |
| Positive | 9 | 6 | |
| Ki67 LI (%) * | 9.5 (1–60) | 16 (1–49) | 0.090 |
| MVD * | 24.5 (3–101) | 32 (7–106) | 0.040 |
| Macrophage infiltration | |||
| Low | 55 | 20 | 0.0070 |
| High | 17 | 19 | |
* Data were presented as median (minimum–max). All other values represent the number of cases. p < 0.05 was considered significant and described in boldface, and 0.05 ≤ p < 0.1 was described in italic. ER: estrogen receptor, HER2: human epidermal growth factor receptor 2, LI: labeling index, MVD: microvessel density and PR: progesterone receptor.